Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?

Glioblastoma (GBM) represents the most frequent primary brain tumor in adults and carries a dismal prognosis despite aggressive, multimodal treatment regimens involving maximal resection, radiochemotherapy, and maintenance chemotherapy. Histologically, GBMs are characterized by a high degree of VEGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Niyazi, Maximilian, Harter, Patrick N., Hattingen, Elke, Rottler, Maya, von Baumgarten, Louisa, Proescholdt, Martin, Belka, Claus, Lauber, Kirsten, Mittelbronn, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823037/
https://www.ncbi.nlm.nih.gov/pubmed/26575171
http://dx.doi.org/10.18632/oncotarget.6320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823037/
https://www.ncbi.nlm.nih.gov/pubmed/26575171
http://dx.doi.org/10.18632/oncotarget.6320

Ejemplares similares